中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Sulfated polymannuroguluronate inhibits Tat-induced SLK cell adhesion via a novel binding site, a KKR spatial triad

文献类型:期刊论文

作者Wu, Yan-lin1; Ai, Jing2; Zhao, Jing-ming3; Xiong, Bing4; Xin, Xiao-jie2; Geng, Mei-yu2; Xin, Xian-liang2; Jiang, Han-dong3
刊名ACTA PHARMACOLOGICA SINICA
出版日期2011-05
卷号32期号:5页码:647-654
关键词sulfated polymannuroguluronate transactivating factor of the HIV-1 virus (Tat) binding site Kaposi's sarcoma heparin mutation HIV-1
ISSN号1671-4083
DOI10.1038/aps.2011.2
文献子类Article
英文摘要Aim: Sulfated polymannuroguluronate (SPMG), a candidate anti-AIDS drug, inhibited HIV replication and interfered with HIV entry into host T lymphocytes. SPMG has high binding affinity for the transactivating factor of the HIV-1 virus (Tat) via its basic domain. However, deletion or substitution of the basic domain affected, but did not completely eliminated Tat-SPMG interactions. Here, we sought to identify other SPMG binding sites in addition to the basic domain. Methods: The potential SPMG binding sites were determined using molecular simulation and a surface plasmon resonance (SPR) based competitive inhibition assay. The effect of SPMG on Tat induced adhesion was evaluated using a cell adhesion assay. Results: The KKR domain, a novel high-affinity heparin binding site, was identified, which consisted of a triad of Lys12, Lys41, and Arg78. The KKR domain, spatially enclosed SPMG binding site on Tat, functions as another binding domain for SPMG. Further functional evaluation demonstrated that SPMG inhibits Tat-mediated SLK cell adhesion by directly binding to the KKR region. Conclusion: The KKR domain is a novel high-affinity binding domain for SPMG. Our findings provide important new insights into the molecular mechanisms of SPMG and a potential therapeutic intervention for Tat-induced cell adhesion.
WOS关键词HIV-1 TAT ; PROTEIN INTERACTIONS ; HEPARAN-SULFATE ; KAPOSIS-SARCOMA ; DRUG CANDIDATE ; GROWTH-FACTOR ; DOMAIN ; OLIGOSACCHARIDES ; MULTIPLE ; SIZE
资助项目National Natural Science Foundation of China[30772884]
WOS研究方向Chemistry ; Pharmacology & Pharmacy
语种英语
CSCD记录号CSCD:4190581
WOS记录号WOS:000290276300013
出版者SHANGHAI INST MATERIA MEDICA
源URL[http://119.78.100.183/handle/2S10ELR8/278545]  
专题新药研究国家重点实验室
中科院受体结构与功能重点实验室
通讯作者Xin, Xian-liang
作者单位1.Ocean Univ China, Sch Med & Pharm, Dept Pharmacol & Glycobiol, Qingdao 266003, Peoples R China;
2.Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, State Key Lab Drug Res, Shanghai 201203, Peoples R China;
3.Qingdao Univ, Affiliated Hosp, Div Resp Med, Med Coll, Qingdao 266003, Peoples R China;
4.Chinese Acad Sci, Shanghai Inst Mat Med, Dept Med Chem, State Key Lab Drug Res, Shanghai 201203, Peoples R China
推荐引用方式
GB/T 7714
Wu, Yan-lin,Ai, Jing,Zhao, Jing-ming,et al. Sulfated polymannuroguluronate inhibits Tat-induced SLK cell adhesion via a novel binding site, a KKR spatial triad[J]. ACTA PHARMACOLOGICA SINICA,2011,32(5):647-654.
APA Wu, Yan-lin.,Ai, Jing.,Zhao, Jing-ming.,Xiong, Bing.,Xin, Xiao-jie.,...&Jiang, Han-dong.(2011).Sulfated polymannuroguluronate inhibits Tat-induced SLK cell adhesion via a novel binding site, a KKR spatial triad.ACTA PHARMACOLOGICA SINICA,32(5),647-654.
MLA Wu, Yan-lin,et al."Sulfated polymannuroguluronate inhibits Tat-induced SLK cell adhesion via a novel binding site, a KKR spatial triad".ACTA PHARMACOLOGICA SINICA 32.5(2011):647-654.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。